ANNUAL RESULTS
Zydus Lifesciences Ltd.
BSE
May 02
885.45
-2.25 ( -0.25%)
Volume
11464
Prev. Close
887.70
Open Price
890.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
May 02
885.60
-2.65 ( -0.30%)
Volume
803068
Prev. Close
888.25
Open Price
887.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE010B01027
|
Market Cap. ( ₹ in Cr. )
|
89112.08
|
P/BV
|
4.08
|
Book Value ( ₹ )
|
216.89
|
|
BSE Code
|
532321
|
52 Week High/Low ( ₹ )
|
1324/795
|
FV/ML
|
1/1
|
P/E(X)
|
23.09
|
|
NSE Code
|
ZYDUSLIFEEQ
|
Book Closure
|
26/07/2024
|
EPS ( ₹ )
|
38.36
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
| Net Sales/Income from operations | 10317.60 | 8421.20 | 7590.00 | 7790.40 | 5967.70 |
| Other Operating Income | 501.10 | 310.40 | 391.90 | 0.00 | 379.70 |
| Total Income From Operations | 10818.70 | 8731.60 | 7981.90 | 7790.40 | 6347.40 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 3001.40 | 2703.50 | 2629.00 | 2346.40 | 1838.30 |
| Purchase of Traded Goods | 283.20 | 362.70 | 288.10 | 153.30 | 97.90 |
| Increase/Decrease in Stocks | -131.70 | 105.10 | -46.90 | -148.30 | 15.50 |
| Employees Cost | 1507.50 | 1321.90 | 1204.90 | 1147.30 | 1077.40 |
| Depreciation | 504.40 | 488.60 | 478.70 | 451.10 | 428.90 |
| Other Expenses | 2099.60 | 1784.00 | 1988.70 | 1972.60 | 1895.20 |
| Total Expenses | 7264.40 | 6765.80 | 6542.50 | 5922.40 | 5353.20 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 3554.30 | 1965.80 | 1439.40 | 1868.00 | 994.20 |
| Other Income | 1084.80 | 548.40 | 178.70 | 78.90 | 849.40 |
| P/L Before Interest, Excpt. Items & Tax | 4639.10 | 2514.20 | 1618.10 | 1946.90 | 1843.60 |
| Interest | 390.70 | 278.20 | 134.90 | 70.90 | 233.90 |
| P/L Before Exceptional Items & Tax | 4248.40 | 2236.00 | 1483.20 | 1876.00 | 1609.70 |
| Exceptional Items | -8.60 | -203.80 | -319.30 | -187.50 | -52.00 |
| P/L Before Tax | 4239.80 | 2032.20 | 1163.90 | 1688.50 | 1557.70 |
| Tax | 798.30 | 503.00 | 306.00 | 212.30 | 204.10 |
| P/L After Tax from Ordinary Activities | 3441.50 | 1529.20 | 857.90 | 1476.20 | 1353.60 |
| Extra Ordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 59.30 |
| Net Profit/Loss For the Period | 3441.50 | 1529.20 | 857.90 | 1476.20 | 1412.90 |
| | | | | | |
| Equity Share Capital | 100.60 | 101.20 | 102.40 | 102.40 | 102.40 |
| Reserves And Surplus | 15615.90 | 13538.20 | 13138.10 | 12642.10 | 11157.80 |
| Equity Dividend Rate | 300.00 | 600.00 | 250.00 | 350.00 | 350.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 34.01 | 15.06 | 8.38 | 14.42 | 13.80 |
| Diluted EPS (Rs.) | 34.01 | 15.06 | 8.38 | 14.42 | 13.80 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 34.01 | 15.06 | 8.38 | 14.42 | 13.80 |
| Diluted EPS (Rs.) | 34.01 | 15.06 | 8.38 | 14.42 | 13.80 |
| | | | | | |
| PBITOE Margin (%) | 32.85 | 22.51 | 18.03 | 23.97 | 15.66 |
| PBTE Margin (%) | 39.26 | 25.60 | 18.58 | 24.08 | 25.35 |
| PBT Margin (%) | 39.18 | 23.27 | 14.58 | 21.67 | 24.54 |
| PAT Margin (%) | 31.81 | 17.51 | 10.74 | 18.94 | 22.25 |